236 related articles for article (PubMed ID: 37626447)
21. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
[TBL] [Abstract][Full Text] [Related]
22. [Alveolar soft part sarcoma in pediatric patients].
Paillard C; Coulomb A; Helfre S; Orbach D
Bull Cancer; 2015 Sep; 102(9):792-8. PubMed ID: 26235420
[TBL] [Abstract][Full Text] [Related]
23. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
[TBL] [Abstract][Full Text] [Related]
24. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.
Kenney S; Vistica DT; Stockwin LH; Burkett S; Hollingshead MG; Borgel SD; Butcher DO; Schrump DS; Shoemaker RH
J Pediatr Hematol Oncol; 2011 Jul; 33(5):360-8. PubMed ID: 21552147
[TBL] [Abstract][Full Text] [Related]
25. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L
Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270
[No Abstract] [Full Text] [Related]
26. Primary Alveolar Soft-Part Sarcoma of the Lung: A Case Report.
Zhao J; Peng J; Liu J; Deng Q; Pang X
Int J Surg Pathol; 2023 Feb; 31(1):98-103. PubMed ID: 35521911
[TBL] [Abstract][Full Text] [Related]
27. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
[TBL] [Abstract][Full Text] [Related]
28. Advances in the management of alveolar soft part sarcoma.
O'Sullivan Coyne G; Naqash AR; Sankaran H; Chen AP
Curr Probl Cancer; 2021 Aug; 45(4):100775. PubMed ID: 34284873
[TBL] [Abstract][Full Text] [Related]
29. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
30. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
31. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
[TBL] [Abstract][Full Text] [Related]
32. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
[TBL] [Abstract][Full Text] [Related]
33. Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature.
Aisner SC; Beebe K; Blacksin M; Mirani N; Hameed M
Skeletal Radiol; 2008 Nov; 37(11):1047-51. PubMed ID: 18594808
[TBL] [Abstract][Full Text] [Related]
34. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.
Orbach D; Brennan B; Casanova M; Bergeron C; Mosseri V; Francotte N; Van Noesel M; Rey A; Bisogno G; Pierron G; Ferrari A
Pediatr Blood Cancer; 2013 Nov; 60(11):1826-32. PubMed ID: 23857870
[TBL] [Abstract][Full Text] [Related]
35. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.
Zhao M; Rao Q; Wu C; Zhao Z; He X; Ru G
Diagn Pathol; 2015 Sep; 10():160. PubMed ID: 26369552
[TBL] [Abstract][Full Text] [Related]
36. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
37. Alveolar soft part sarcoma in a child - a case report.
Bartoš V; Sejnová D; Skálová A; Béder I
Klin Onkol; 2023; 36(4):396-400. PubMed ID: 37877532
[TBL] [Abstract][Full Text] [Related]
38. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
[TBL] [Abstract][Full Text] [Related]
40. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
